Join
Live feed
·
INSIDERFilingvia Quantisnow
Flexion Therapeutics, Inc. logo

SEC Form 4: D. Michael Clayman was granted 119,500 units of Common Stock and disposed of $108,559 worth of Common Stock (8,776 units at $12.37), increasing ownership by 71% to 266,901 units

ByQuantisnow·Wall Street's wire, on your screen.
FLXN· Flexion Therapeutics, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FLXN (Flexion Therapeutics, Inc.) and more on Quantisnow.

SEC Form 4: D. Michael Clayman was granted 119,500 units of Common Stock and disposed of $108,559 worth of Common Stock (8,776 units at $12.37), increasing ownership by 71% to 266,901 units | Quantisnow